Shares of self defense company AXON (NASDAQ:AXON) jumped 2.9% in the afternoon session after it announced a deal to acquire Prepared, an AI-powered emergency communications company. The stock's rise ...

Axon stock is up more than 3,000% over the last decade. The company has built a unique business in law enforcement tech. The business is still growing briskly and expanding into new technologies. The ...

Axon stock is up more than 3,000% over the last decade. The company has built a unique business in law enforcement tech. The business is still growing briskly and expanding into new technologies. You ...

Axon is rated a 'Buy' due to strong recurring revenue growth, expanding AI integration, and a dominant market position in security technology. AXON's Q2 2025 revenue rose 33% YoY to $669 million, with ...

Axon said it would acquire Prepared, an emergency communications company, yesterday. The price was estimated to be $800 million-$900 million. While the deal makes sense over the longer term, Axon's ...

Axon stock is up more than 3,000% over the last decade. The company has built a unique business in law enforcement tech. The business is still growing briskly and expanding into new technologies. 10 ...

Global performance and lifestyle brand Saucony unveiled its latest Saucony SILO collection, a fusion of heritage, luxury, and performance, at Paris Fashion Week in June. The footwear capsule is now ...

Axon Enterprise (NASDAQ:AXON), best known for its Taser devices, is undergoing a transformation that positions it as a leader in a much broader public safety technology market, according to new ...

PHOENIX — Scottsdale-based political action committee Taxpayers Against Awful Apartment Zoning Exemptions (TAAAZE) plans to file a lawsuit on Thursday against the state of Arizona and city of ...

US sports brand Saucony has ended its sponsorship of the Jerusalem Marathon - a race that cuts through illegally occupied East Jerusalem - following boycott calls from running communities in the UK ...

Funding supports clinical trials of a minimally invasive therapy targeting a root cause of heart failure; co-founder Zoar Engelman, PhD, appointed CEO The financing will accelerate Axon's next phase ...

Two sides have been battling behind-the-scenes and in the court of public opinion for nearly a year. Now, the fight is official, with lawyers set to face off over “the Axon bill” at Maricopa County ...